VUNO Presents the Future of Medical AI Solutions at RSNA 2019

CHICAGO,Nov. 27,2019 -- VUNOInc.,a medical AI solution developer and a member companyofthe Born2Global Centre,will participate inRSNA (Radiological Society of North America) 2019in Chicago,December 1-8.Booth:North Hall Level2,#11132.

VUNO will participate in RSNA 2019 and introduce many upgraded AI solutions.

Four Consecutive Years of Participation

VUNO will participate in RSNA for the fourth year this year.VUNOplans to run a booth where people can experiencea series of VUNO Med solutions,introducing its world-class technology to radiologists from around the world through AI Theater presentations and research sharing sessions. The reliable and robust performance of Vuno's AI-enabled softwares puts the company in the unrivalled leading position in the local market. In addition to obtaining FDA and CE certifications from home and abroad,the company is laying the foundation to make inroads into overseas markets by partnering withleading global medical device and pharmaceutical companies.

VUNO will showcase its VUNO Med AI solutions: VUNO Med®-BoneAge,VUNO Med®-DeepBrain,VUNO Med®-Chest X-ray,and VUNO Med®-LungCT AI. All VUNO Med solutions can be integrated into PACS and other existing medical systemsenhancing user convenience and significantly reducing reading time for diagnosis. The solutions also generatestructured and detailed reports to support objective and efficient communication between medical personnel and between medical staff and patients.

Demonstrating Corporate Performance through AI Theater &Oral PresentationSessions

Jin-Kyeong Sung (MD,PhD),radiologist,and Hyunho Park (PhD),a medical director at VUNO,will participate inAI Theater sessions,which will be held at 11:30 am on December 3. They will introducemajorachievements that VUNO has accomplished since its establishment in2014 as Korea's first medical AI solutions company.A wide range of topics covering the entire cycle of medical AI will be discussed fromR&D,clinical validation,clinical application andregulatory approval tocommercialization.Vuno's future plans will be part of the talks in its effort to further improve the efficiency of overall clinical environments that includea variety of medical imaging-baseddiagnostic support systems,biosignals,and automatic speech recognition. In addition,its expansion planto developan optimal decision-making platform enabled by more accurate prediction ofprognosis and treatment responsewill be shared.

The company willalso talk about the clinical applicationsand performance of medical AI solutions during theoral presentation sessions.For more details,visit the VUNO website athttps://www.vuno.co/

Lee Ye-ha,CEO of VUNO,said "We are delightedto share our achievements with leading AI companies at one of the most prestigious gatherings in the field of radiology,RSNA 2019," and "VUNO will continue to make all-out effort in AI R&D andclinical testing and validation of developed solutions."

Media Contact

VUNO Inc.:rim@vuno.co

Born2Global Centre:jlee@born2global.com

View original content to download multimedia:/news-releases/vuno-presents-the-future-of-medical-ai-solutions-at-rsna-2019-300966040.html